Allegiance Financial Group Advisory Services LLC Makes New $210,000 Investment in Medpace Holdings, Inc. (NASDAQ:MEDP)

Allegiance Financial Group Advisory Services LLC bought a new position in Medpace Holdings, Inc. (NASDAQ:MEDP) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 631 shares of the company’s stock, valued at approximately $210,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Centaurus Financial Inc. lifted its position in Medpace by 2.0% in the 3rd quarter. Centaurus Financial Inc. now owns 1,513 shares of the company’s stock worth $505,000 after buying an additional 29 shares in the last quarter. Lindenwold Advisors INC lifted its position in Medpace by 1.6% in the 3rd quarter. Lindenwold Advisors INC now owns 2,026 shares of the company’s stock worth $676,000 after buying an additional 32 shares in the last quarter. Stephens Inc. AR lifted its position in Medpace by 4.9% in the 4th quarter. Stephens Inc. AR now owns 752 shares of the company’s stock worth $250,000 after buying an additional 35 shares in the last quarter. M&T Bank Corp raised its holdings in shares of Medpace by 1.2% during the 3rd quarter. M&T Bank Corp now owns 3,199 shares of the company’s stock valued at $1,068,000 after purchasing an additional 37 shares in the last quarter. Finally, Custom Index Systems LLC raised its holdings in shares of Medpace by 3.0% during the 4th quarter. Custom Index Systems LLC now owns 1,290 shares of the company’s stock valued at $429,000 after purchasing an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Medpace Price Performance

Shares of MEDP opened at $339.48 on Thursday. The company has a market capitalization of $10.34 billion, a PE ratio of 26.88, a price-to-earnings-growth ratio of 3.81 and a beta of 1.36. The company’s fifty day moving average price is $343.04 and its 200 day moving average price is $346.19. Medpace Holdings, Inc. has a one year low of $302.01 and a one year high of $459.77.

Medpace (NASDAQ:MEDP) last posted its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Analysts anticipate that Medpace Holdings, Inc. will post 12.29 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird raised their price target on shares of Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $381.44.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.